Metrifonate

DB11473

small molecule vet_approved

Deskripsi

Metrifonate or trichlorfon is an irreversible organophosphate acetylcholinesterase inhibitor. It is a prodrug which is activated non-enzymatically into 2,2-dichlorovinyl dimethyl phosphate.

Struktur Molekul 2D

Berat 257.437
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

292 Data
Dipyridamole The therapeutic efficacy of Metrifonate can be decreased when used in combination with Dipyridamole.
Ephedrine Metrifonate may increase the neuromuscular blocking activities of Ephedrine.
Bambuterol Metrifonate may increase the neuromuscular blocking activities of Bambuterol.
Clevidipine Metrifonate may increase the neuromuscular blocking activities of Clevidipine.
Sar9, Met (O2)11-Substance P Metrifonate may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.
Mirabegron Metrifonate may increase the neuromuscular blocking activities of Mirabegron.
Moxisylyte Metrifonate may increase the neuromuscular blocking activities of Moxisylyte.
Propacetamol Metrifonate may increase the neuromuscular blocking activities of Propacetamol.
Procaine Metrifonate may increase the neuromuscular blocking activities of Procaine.
Cocaine Metrifonate may increase the neuromuscular blocking activities of Cocaine.
Trimethaphan Metrifonate may increase the neuromuscular blocking activities of Trimethaphan.
Doxacurium Metrifonate may increase the neuromuscular blocking activities of Doxacurium.
Chloroprocaine Metrifonate may increase the neuromuscular blocking activities of Chloroprocaine.
Tubocurarine Metrifonate may increase the neuromuscular blocking activities of Tubocurarine.
Aclidinium Metrifonate may increase the neuromuscular blocking activities of Aclidinium.
Butyrylthiocholine Metrifonate may increase the neuromuscular blocking activities of Butyrylthiocholine.
Oxybuprocaine Metrifonate may increase the neuromuscular blocking activities of Oxybuprocaine.
Benzonatate Metrifonate may increase the neuromuscular blocking activities of Benzonatate.
Succinylcholine The metabolism of Succinylcholine can be decreased when combined with Metrifonate.
Tramadol The therapeutic efficacy of Tramadol can be decreased when used in combination with Metrifonate.
Trospium The therapeutic efficacy of Trospium can be decreased when used in combination with Metrifonate.
Oxyphenonium The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Metrifonate.
Butabarbital The therapeutic efficacy of Butabarbital can be decreased when used in combination with Metrifonate.
Butalbital The therapeutic efficacy of Butalbital can be decreased when used in combination with Metrifonate.
Benzatropine The therapeutic efficacy of Benzatropine can be decreased when used in combination with Metrifonate.
Ziprasidone The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Metrifonate.
Disopyramide The therapeutic efficacy of Disopyramide can be decreased when used in combination with Metrifonate.
Talbutal The therapeutic efficacy of Talbutal can be decreased when used in combination with Metrifonate.
Pentobarbital The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Metrifonate.
Amitriptyline The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Metrifonate.
Ipratropium The therapeutic efficacy of Ipratropium can be decreased when used in combination with Metrifonate.
Methadone The therapeutic efficacy of Methadone can be decreased when used in combination with Metrifonate.
Olanzapine The therapeutic efficacy of Olanzapine can be decreased when used in combination with Metrifonate.
Metixene The therapeutic efficacy of Metixene can be decreased when used in combination with Metrifonate.
Terfenadine The therapeutic efficacy of Terfenadine can be decreased when used in combination with Metrifonate.
Buclizine The therapeutic efficacy of Buclizine can be decreased when used in combination with Metrifonate.
Clozapine The therapeutic efficacy of Clozapine can be decreased when used in combination with Metrifonate.
Doxylamine The therapeutic efficacy of Doxylamine can be decreased when used in combination with Metrifonate.
Trihexyphenidyl The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Metrifonate.
Oxyphencyclimine The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Metrifonate.
Procyclidine The therapeutic efficacy of Procyclidine can be decreased when used in combination with Metrifonate.
Profenamine The therapeutic efficacy of Profenamine can be decreased when used in combination with Metrifonate.
Secobarbital The therapeutic efficacy of Secobarbital can be decreased when used in combination with Metrifonate.
Promazine The therapeutic efficacy of Promazine can be decreased when used in combination with Metrifonate.
Hyoscyamine The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Metrifonate.
Cyproheptadine The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Metrifonate.
Imipramine The therapeutic efficacy of Imipramine can be decreased when used in combination with Metrifonate.
Methscopolamine bromide The therapeutic efficacy of Methscopolamine bromide can be decreased when used in combination with Metrifonate.
Metharbital The therapeutic efficacy of Metharbital can be decreased when used in combination with Metrifonate.
Fluoxetine The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Metrifonate.
Chlorpromazine The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Metrifonate.
Darifenacin The therapeutic efficacy of Darifenacin can be decreased when used in combination with Metrifonate.
Tridihexethyl The therapeutic efficacy of Tridihexethyl can be decreased when used in combination with Metrifonate.
Triflupromazine The therapeutic efficacy of Triflupromazine can be decreased when used in combination with Metrifonate.
Dextromethorphan The therapeutic efficacy of Dextromethorphan can be decreased when used in combination with Metrifonate.
Anisotropine methylbromide The therapeutic efficacy of Anisotropine methylbromide can be decreased when used in combination with Metrifonate.
Nortriptyline The therapeutic efficacy of Nortriptyline can be decreased when used in combination with Metrifonate.
Amoxapine The therapeutic efficacy of Amoxapine can be decreased when used in combination with Metrifonate.
Atropine The therapeutic efficacy of Atropine can be decreased when used in combination with Metrifonate.
Thiopental The therapeutic efficacy of Thiopental can be decreased when used in combination with Metrifonate.
Nicardipine The therapeutic efficacy of Nicardipine can be decreased when used in combination with Metrifonate.
Mecamylamine The therapeutic efficacy of Mecamylamine can be decreased when used in combination with Metrifonate.
Pirenzepine The therapeutic efficacy of Pirenzepine can be decreased when used in combination with Metrifonate.
Paroxetine The therapeutic efficacy of Paroxetine can be decreased when used in combination with Metrifonate.
Homatropine methylbromide The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Metrifonate.
Scopolamine The therapeutic efficacy of Scopolamine can be decreased when used in combination with Metrifonate.
Isoflurane The therapeutic efficacy of Isoflurane can be decreased when used in combination with Metrifonate.
Benzquinamide The therapeutic efficacy of Benzquinamide can be decreased when used in combination with Metrifonate.
Clidinium The therapeutic efficacy of Clidinium can be decreased when used in combination with Metrifonate.
Propiomazine The therapeutic efficacy of Propiomazine can be decreased when used in combination with Metrifonate.
Propantheline The therapeutic efficacy of Propantheline can be decreased when used in combination with Metrifonate.
Primidone The therapeutic efficacy of Primidone can be decreased when used in combination with Metrifonate.
Dicyclomine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Metrifonate.
Biperiden The therapeutic efficacy of Biperiden can be decreased when used in combination with Metrifonate.
Brompheniramine The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Metrifonate.
Methylphenobarbital The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Metrifonate.
Quinidine The therapeutic efficacy of Quinidine can be decreased when used in combination with Metrifonate.
Amantadine The therapeutic efficacy of Amantadine can be decreased when used in combination with Metrifonate.
Maprotiline The therapeutic efficacy of Maprotiline can be decreased when used in combination with Metrifonate.
Methantheline The therapeutic efficacy of Methantheline can be decreased when used in combination with Metrifonate.
Hexafluronium The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Metrifonate.
Cycrimine The therapeutic efficacy of Cycrimine can be decreased when used in combination with Metrifonate.
Desloratadine The therapeutic efficacy of Desloratadine can be decreased when used in combination with Metrifonate.
Glycopyrronium The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Metrifonate.
Tolterodine The therapeutic efficacy of Tolterodine can be decreased when used in combination with Metrifonate.
Oxybutynin The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Metrifonate.
Promethazine The therapeutic efficacy of Promethazine can be decreased when used in combination with Metrifonate.
Diphenhydramine The therapeutic efficacy of Diphenhydramine can be decreased when used in combination with Metrifonate.
Pentolinium The therapeutic efficacy of Pentolinium can be decreased when used in combination with Metrifonate.
Doxepin The therapeutic efficacy of Doxepin can be decreased when used in combination with Metrifonate.
Flavoxate The therapeutic efficacy of Flavoxate can be decreased when used in combination with Metrifonate.
Desipramine The therapeutic efficacy of Desipramine can be decreased when used in combination with Metrifonate.
Orphenadrine The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Metrifonate.
Phenobarbital The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Metrifonate.
Escitalopram The therapeutic efficacy of Escitalopram can be decreased when used in combination with Metrifonate.
Quetiapine The therapeutic efficacy of Quetiapine can be decreased when used in combination with Metrifonate.
Levacetylmethadol The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Metrifonate.
Diphenidol The therapeutic efficacy of Diphenidol can be decreased when used in combination with Metrifonate.
Aripiprazole The therapeutic efficacy of Aripiprazole can be decreased when used in combination with Metrifonate.
Chlorprothixene The therapeutic efficacy of Chlorprothixene can be decreased when used in combination with Metrifonate.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 8094783
    Czeizel AE, Elek C, Gundy S, Metneki J, Nemes E, Reis A, Sperling K, Timar L, Tusnady G, Viragh Z: Environmental trichlorfon and cluster of congenital abnormalities. Lancet. 1993 Feb 27;341(8844):539-42.
  • PMID: 1855006
    Martinez F, Jarillo JA, Orus MI: Interactions between trichlorfon and three Chlorophyceae. Bull Environ Contam Toxicol. 1991 Apr;46(4):599-605.
  • PMID: 19372080
    Wu ML, Deng JF: Acute hemolysis caused by incidental trichlorfon exposure. J Chin Med Assoc. 2009 Apr;72(4):214-8. doi: 10.1016/S1726-4901(09)70058-9.
  • PMID: 1768954
    Orus MI, Marco E: Disappearance of trichlorfon from cultures with different cyanobacteria. Bull Environ Contam Toxicol. 1991 Sep;47(3):392-7.
  • PMID: 19775726
    Xu WN, Liu WB, Liu ZP: Trichlorfon-induced apoptosis in hepatocyte primary cultures of Carassius auratus gibelio. Chemosphere. 2009 Nov;77(7):895-901. doi: 10.1016/j.chemosphere.2009.08.043. Epub 2009 Sep 22.
  • PMID: 24122545
    Wang X, Tang Q, Wang Q, Qiao X, Xu Z: Study of a molecularly imprinted solid-phase extraction coupled with high-performance liquid chromatography for simultaneous determination of trace trichlorfon and monocrotophos residues in vegetables. J Sci Food Agric. 2014 May;94(7):1409-15. doi: 10.1002/jsfa.6429. Epub 2013 Oct 31.
  • PMID: 6578181
    Authors unspecified: Trichlorfon. IARC Monogr Eval Carcinog Risk Chem Hum. 1983 Jan;30:207-31.
  • PMID: 869797
    Dobson KJ: Trichlorfon toxicity in pigs. Aust Vet J. 1977 Mar;53(3):115-7.
Menampilkan 8 dari 12 artikel.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul